Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?

Pancreatic cancer (PC) remains one of the deadliest malignancies worldwide. Chemoresistance is a significant clinical problem in pancreatic ductal adenocarcinoma (PDAC) and numerous potential mechanisms have been demonstrated but much remains to be understood. To overcome the existing limitations in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Autores principales: Luo, Wenhao, Yang, Gang, Qiu, Jiangdong, Luan, Jingyang, Zhang, Ying, You, Lei, Feng, Mengyu, Zhao, Fangyu, Liu, Yueze, Cao, Zhe, Zheng, Lianfang, Zhang, Taiping, Zhao, Yupei
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797580/
https://ncbi.nlm.nih.gov/pubmed/31475468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2384
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares